300463MaccuraSZSE

Maccura Biotechnology Co., Ltd.

迈克生物

300463

Shenzhen Stock Exchange

BoardChiNext of Shenzhen Stock Exchange
IndustryPharmaceutical Manufacturing
ISINCNE1000020H3
ListedMay 28, 2015
Websitewww.maccura.com
IR Emailzqb@maccura.com
Phone(+86)028-61619001
Sourcecninfo.com.cn
AddressNO. 1006 Qihuang 1st Road, Shuangliu District, Chengdu

Company Overview

Maccura Biotechnology Co., Ltd. is a pharmaceutical manufacturing company founded in 1994 and listed on the ChiNext board of the Shenzhen Stock Exchange in 2015. The company specializes in the research and development, manufacture, and sales of in vitro diagnostic (IVD) products and related services. Maccura is recognized as a High-Tech Enterprise and has achieved various certifications, including ISO13485 and CE certification for its products. The company's operations encompass a comprehensive industrial chain that includes the development of biological raw materials, IVDs, reagents, calibration products, and quality-control products. Maccura's technology platforms cover clinical chemistry, immunoassay, point-of-care testing (POCT), hematology, coagulation, molecular diagnosis, and pathology, addressing over 90% of clinical laboratory demands. With a strong focus on innovation and quality management, Maccura has established a robust market presence in China, supported by a network of subsidiaries and offices across the country, and collaborates with leading R&D institutions to enhance its product offerings and services.

AI-generated from company disclosures and CNInfo data.

Company Profile

1. Technology and R&D Advantages The company has the world-leading R&D team. Led by the chief scientists, R&D Center has established several technology development platforms which cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, molecular diagnosis and biomass etc. The company has been enriching and optimizing the product line through continuous research and development investment. 2. Advantages of the System of Production and Quality Management The company possesses world-class production conditions and production management level. The products cover 90% needs of medical laboratories. Maccura become the first enterprise member at IFCC and is the first batch of IVD enterprises in China to build reference laboratories for measurement traceability work. 3. Advantages of Product and Marketing Services The company has abundant market management experience and channel management ability, professional sales service capability and product resource integration advantages, which can provide perfect professional services, including the comprehensive design and management of laboratory, actuary of the purchasing of configurations, the optimization of the processes etc. for the product dealers and end customers. The company promotes the marketing network construction actively. At present, there are 13 wholly owned and controlling subsidiaries, 25 offices, and the business covers all regions of China except HK, Macao and Taiwan.

60 announcements tracked· Last: June 22, 2026

Key Financials

As of 2026-06-20T00:00:00.000+00:00
Revenue¥475.3M
Net Profit¥9.0M
ROE0.14%
Debt Ratio21.00%
Monetary Funds¥720.5M
Receivables¥1.05bn
Goodwill¥51.0M
Total Shares604.7M

Announcements

60 totalCSV

Notes & Comments

Sign in to leave a comment or private note.

No notes or comments yet.